According to TG Therapeutics's latest financial reports the company's current revenue (TTM) is $0.23 B. In 2022 the company made a revenue of $2.78 M a decrease over the years 2021 revenue that were of $6.68 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.23 B | 8293.07% |
2022 | $2.78 M | -58.38% |
2021 | $6.68 M | 4300.66% |
2020 | $0.15 M | 0% |
2019 | $0.15 M | 0% |
2018 | $0.15 M | -0.06% |
2017 | $0.15 M | -0.19% |
2016 | $0.15 M | 0% |
2015 | $0.15 M | 0% |
2014 | $0.15 M | 0% |
2013 | $0.15 M | 699.98% |
2012 | $0.01 M | |
2011 | N/A | |
2010 | N/A | |
2009 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Alkermes ALKS | $1.66 B | 611.88% | ๐ฎ๐ช Ireland |
Dr. Reddy's RDY | $3.28 B | 1,305.11% | ๐ฎ๐ณ India |